Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print

Promotions & Moves

Related Searches:

Filter by:

October 29, 2008
Nicholas Moore, Ph.D. has been named director of development and pharmacology, discovery R&D, AMRI. Dr. Moore will be responsible for the company's internal R&D portfolio, including the progression of discovery phase programs and the guidance…   Read More »
October 29, 2008
Wendy Shusko has been named chief operating officer of WellSpring Pharmaceutical. In her new role, Ms. Shusko will maintain financial responsibilities as well as broaden her oversight to operations with an initial focus on the newly acquired consumer…   Read More »
October 27, 2008
Cipher Pharmaceuticals has appointed John MacInnis as vice president, portfolio development and licensing. Mr. MacInnis will be responsible for identifying and evaluating pipeline products and technologies, and pursuing strategic alliances and partne…   Read More »
October 21, 2008
Shabbir Anik, Ph.D. will join Althea Technologies as president and chief executive officer. Dr. Anik will lead the company's expansion of its product development, clinical trial and commercial manufacturing services.      &n…   Read More »
October 13, 2008
Paul K. Wotton, Ph.D., has been named president and chief executive officer of Antares Pharma. Dr. Wotton previously served as president and chief operating officer, the titles he held upon joining the company in July 2008. Concurrently, Jack E. Stov…   Read More »
October 9, 2008
Dr. Christophe Berthoux has been named executive vice president, global sales and marketing and chief commercial officer, Charles River Laboratories. In this newly created position, Dr. Berthoux will lead the global realignment of the company's sales…   Read More »
October 9, 2008
Muhammad Asif, Ph.D. has been named director of analytical development, and Paul Maffuid, Ph.D. has been named senior vice president of operations, Irvine Pharmaceutical Services. Dr. Asif has more than 17 years of experience including supporting…   Read More »
October 3, 2008
Alba Therapeutics Corp. has made several promotions. Linda Arterburn, Ph.D., has been promoted to vice president of preclinical development and program management. Francisco Leon, M.D., Ph.D., has been promoted to vice president, clinical development…   Read More »
October 2, 2008
Christopher Perley has been named vice president and general manager of Bristol-Myers Squibb's Devens biologics manufacturing facility. Mr. Perley will be responsible for continuing the supervision of the project to build the Devens facility and will…   Read More »
October 1, 2008
Gergely Makara, Ph.D. has been named director of chemistry for European operations, AMRI. Dr. Makara has responsibility for all European chemistry products and services including custom synthesis, medicinal chemistry, analytical services, library des…   Read More »
October 1, 2008
Tara Webb has been appointed senior director of business development, Accelerated Community Oncology Research Network (ACORN). Ms. Webb will focus exclusively in the field of oncology, working closely with a select group of sponsors.    &n…   Read More »
September 29, 2008
Jon Brewer has been named vice president, sales and marketing, BASi. He replaces Emilio Córdova who has resigned to pursue other opportunities. Mr. Brewer has nearly 25 years of experience as a sales and marketing executive in the pharmaceutic…   Read More »
September 23, 2008
Ronald Shoup has been named executive director of Pharma Services, AIT Laboratories. Mr. Shoup was the former co-founder and chief scientific officer of West Lafayette, IN-based Bioanalytical Systems, Inc. (BASi). "Ron brings 30 years of lead…   Read More »
September 22, 2008
John J. Dupree has joined Girindus as senior director, business development. Mr. Dupree has more than 34 years of sales, business management, and corporate accounts management experience. He spent his entire career with Eastman Chemical Co. as a seni…   Read More »
September 18, 2008
Roger Rush, Ph.D. has been named vice president of preclinical development, Wolfe Laboratories. Dr. Rush has more than 25 years of international experience in pharmaceutical R&D with a focus on preclinical research, development, and program manag…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On